Utah Medical Products Inc (UTMD) Files 10-K for the Fiscal Year Ended on December 31, 2018

Utah Medical Products Inc (UTMD, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Utah Medical Products Inc is in the business of producing medical devices that are predominantly proprietary, disposable and for hospital use. The firm's product includes Electrosurgical Pens, Footswitches, Fuses, Dispersive Pads and others. Utah Medical Products Inc has a market cap of $316.180 million; its shares were traded at around $85.00 with a P/E ratio of 17.19 and P/S ratio of 7.54. The dividend yield of Utah Medical Products Inc stocks is 1.27%. Utah Medical Products Inc had annual average EBITDA growth of 8.70% over the past ten years.

For the last quarter Utah Medical Products Inc reported a revenue of $9.76 million, compared with the revenue of $10.20 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $42.0 million, an increase of 1.4% from last year. For the last five years Utah Medical Products Inc had an average revenue growth rate of 0.5% a year.

The reported diluted earnings per share was $4.95 for the year, an increase of 117.1% from previous year. Over the last five years Utah Medical Products Inc had an EPS growth rate of 4.8% a year. The Utah Medical Products Inc had a decent operating margin of 44.52%, compared with the operating margin of 45.9% a year before. The 10-year historical median operating margin of Utah Medical Products Inc is 37.01%. The profitability rank of the company is 6 (out of 10).

At the end of the fiscal year, Utah Medical Products Inc has the cash and cash equivalents of $51.1 million, compared with $39.9 million in the previous year. The company had no long term debt. The interest coverage to the debt is at a comfortable level of 23.2. Utah Medical Products Inc has a financial strength rank of 9 (out of 10).

At the current stock price of $85.00, Utah Medical Products Inc is traded at 61.7% premium to its historical median P/S valuation band of $52.57. The P/S ratio of the stock is 7.54, while the historical median P/S ratio is 4.65. The stock lost 5.51% during the past 12 months.

Directors and Officers Recent Trades:

  • Director Barbara A Payne sold 1,525 shares of UTMD stock on 02/27/2019 at the average price of $85.76. The price of the stock has decreased by 0.89% since.
  • Director Barbara A Payne sold 1 shares of UTMD stock on 02/20/2019 at the average price of $92. The price of the stock has decreased by 7.61% since.
  • Director Barbara A Payne sold 2,468 shares of UTMD stock on 02/15/2019 at the average price of $92.28. The price of the stock has decreased by 7.89% since.

For the complete 20-year historical financial data of UTMD, click here.